Itoly 200mg Capsule contains Itraconazole, a broad-spectrum triazole antifungal agent indicated for the treatment of various fungal infections. Itraconazole exerts its antifungal activity by inhibiting the cytochrome P450-dependent enzyme lanosterol 14-α-demethylase, which is essential for the synthesis of ergosterol, a critical component of fungal cell membranes. Disruption of ergosterol synthesis compromises the integrity of the fungal cell membrane, leading to increased permeability and ultimately fungal cell death. Itoly 200mg is primarily prescribed for the management of infections such as histoplasmosis, blastomycosis, aspergillosis, onychomycosis, and other systemic and superficial mycoses caused by susceptible fungal species. The capsule formulation ensures adequate bioavailability, with absorption enhanced when taken with food. Dosage and duration of therapy should be individualized based on the type and severity of infection, patient response, and clinical guidelines. Caution is advised in patients with hepatic impairment or congestive heart failure, and potential drug interactions should be carefully monitored due to itraconazole’s inhibition of cytochrome P450 enzymes. Common adverse effects include gastrointestinal disturbances, headache, and rash. Itoly 200mg Capsule should be used under strict medical supervision to ensure efficacy and minimize the risk of adverse events.